Grace Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.9%.

Top 23 shareholders own 59.33% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.9%	Vimal Kavuru	1,614,399	US$5.3m	0%	no data
9.46%	ADAR1 Capital Management, LLC	959,571	US$3.1m	0%	0.54%
9.19%	SS Pharma LLC	931,743	US$3.1m	0%	no data
7.71%	Iyer Sambamurty	781,592	US$2.6m	0%	no data
6.32%	Aigh Capital Management, LLC	641,083	US$2.1m	0%	1.01%
4.88%	Bank of America Corporation, Asset Management Arm	494,698	US$1.6m	0%	no data
3.65%	S. Kottayil	370,354	US$1.2m	0%	no data
1.23%	Kottayil Grace Pharma LLC	124,344	US$407.8k	0%	no data
0.37%	Edward Neugeboren	37,895	US$124.3k	0%	no data
0.21%	Prashant Kohli	21,357	US$70.0k	0%	no data
0.16%	Renaissance Technologies LLC	16,147	US$53.0k	0%	no data
0.11%	Amresh Kumar	11,118	US$36.5k	0%	no data
0.03%	Geode Capital Management, LLC	3,058	US$10.0k	-2.33%	no data
0.027%	Tower Research Capital Europe Limited	2,732	US$9.0k	0%	no data
0.027%	National Bank Investments Inc.	2,719	US$8.9k	-6.27%	no data
0.019%	Morgan Stanley, Investment Banking and Brokerage Investments	1,882	US$6.2k	0%	no data
0.0054%	RBC Dominion Securities Inc., Asset Management Arm	543	US$1.8k	-7.02%	no data
0.0031%	Tidal Investments LLC	309	US$1.0k	0%	no data
0.001%	Activest Wealth Management, LLC	104	US$342.6	0%	no data
0.00028%	UBS Asset Management AG	28	US$93.1	-99.6%	no data
0.00028%	Fédération des Caisses Desjardins du Québec, Asset Management Arm	28	US$93.1	0%	no data
0.00017%	JPMorgan Chase & Co, Brokerage and Securities Investments	17	US$56.5	0%	no data
0.00006%	IFP Advisors, LLC	6	US$20.0	0%	no data